Authors


Joette Gdovin Bergeson, PhD

Latest:

US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus

Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.



Virginia Bartok, RPh

Latest:

Myocardial Infarction, Blood Sugar, and Diabetes: Treatment After Discharge

Medication omission at discharge is the most common type of medication discrepancy.


Richard Engleka, Regional Operations Director at Walgreens

Latest:

Industry Takeaways From Asembia

As it is every year, the Asembia Summit was filled with a plethora of information that allowed for networking, business development, and personal development.


Amy M. Egras, PharmD, BCPS

Latest:

Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide

Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.


Anthony Palmieri, RPh, MBA

Latest:

Generic Drug Trends in the United States

By 2012, we estimate that more than 3 of every 4 prescriptions will be filled with a generic drug.


Kathleen M. Vest, PharmD, CDE, BCACP

Latest:

Addressing Immunizations in Pregnant and Lactating Women

The immunization status of pregnant and lactating women should be routinely assessed, and indicated vaccines should be recommended.


Jessica Smith, Assistant Editor

Latest:

Innovative Pharmacy Caters Solely to Women

A women's pharmacy that opened last week in Vancouver is the first of its kind in North America. More than a pharmacy, Lu's: A Pharmacy for Women offers everything from private counseling areas and a resource library to support groups and other women-centric programs.


Laressa Bethishou, PharmD, BCPS

Latest:

Pneumonia Vaccines: Current Recommendations and Advocacy Opportunities

Pneumonia is a bacterial, viral, or fungal infection of the lungs that can be mild to severe in presentation.



Joanne Canedo, PharmD Candidate

Latest:

Tip of the Week: Strategic Planning for Pharmacy Emergency Preparedness and Response Activities

Pharmacy organizations have produced advisories to guide workflow and optimize services, yet there still exists a gap in further integration of pharmacists into public health and safety initiatives.


Sharon J. Rolnick, PhD, MPH

Latest:

Barriers to and Facilitators of Medication Adherence

This study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.


Jena Ivey Burkhart, PharmD, BCPS, CPP

Latest:

JNC 8 and Older Adults: A Review of the Evidence

New Guideline for Blood Pressure Management in Older Patients



Specialty Pharmacy Times Staff

Latest:

Pharmacist-Administered ART Adherence Clinic Makes Inroads

Pharmacists can resolve ART adherence problems to achieve HIV viral suppression


Dawn S. Knudsen, PharmD

Latest:

Sleep Disorders: Treatment Options for a Tiring Problem

Various pharmacologic agents are available for sleep disorders, which affect a large portion of the US population.


Sandra Leal, PharmD, CDE

Latest:

Long-Acting Insulins for the Treatment of Type 2 Diabetes

A look at the role of basal insulin in the treatment of type 2 diabetes.




Bong-Chul Chu, PhD

Latest:

Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.



HCPLive Staff

Latest:

FDA Approves Alemtuzumab for Relapsing Forms of Multiple Sclerosis

The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.


Brent Carlson, PharmD, BCPS

Latest:

Latent Tuberculosis After the Use of Etanercept

TNF-alpha inhibitors are used to treat a number of inflammatory conditions.


Andrea Lee, PharmD Candidate

Latest:

TXNIP inhibitors: A New Class of Agents for Diabetes Treatment

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.


Kim Milenski, RPh

Latest:

Value-Based Care in Specialty Populations: High-Quality Clinical Management of Home Infusion Hemophilia Patients Reduces Costs, Maintains Outcomes

High-quality clinical management of home infusion hemophilia patients reduces costs and maintains outcomes.



Lauren Meyer, PharmD, MSPBA

Latest:

Something Has to Give: Balancing Specialty Drug Cost With Value

The ever-growing price tag for new specialty drugs is testing the limits of the health care system to afford these revolutionary therapies.


Swana Thomas, PharmD-MPH Candidate 2018

Latest:

An Indian Health Service Ambulatory Care Resident Describes Her Experience

An interview with Dr. Kaley Holmstrom, an IHS Ambulatory Care Resident at the Fort Defiance Indian Hospital in Fort Defiance, AZ


Stefanie Ferreri, PharmD

Latest:

Local Health Care Partnerships Are Strongly Associated With Successful Enhanced Community Pharmacy Services

Incorporating community pharmacists into team-based care models is recommended as a strategy for improving health care access and quality while reducing health care costs.


Lana Borno, PharmD

Latest:

How to Treat Common Skin Infections

Helpful advice for your patients on treating bacterial skin infections.